Login
$CEPS
$10.11 -$0.01 (0.1%) Close

Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Current Assets:
Cash
Prepaid expenses
Total Current Assets
Available-for-sale debt securities held in Trust Account, at fair value
Deferred offering costs
Other assets
Total Assets
Liabilities and Shareholder’s Equity (Deficit):
Current Liabilities:
Accrued expenses
Notes payable – related party
Total Liabilities
Class A ordinary shares subject to possible redemption, 11,500,000 and 0 shares issued and outstanding at redemption value of $10.14 and $0 per share as of June 30, 2026 and December 31, 2025, respectively
Shareholders’ Equity (Deficit):
Ordinary shares, value
Class A Ordinary Shares
Class B Ordinary Shares
Additional paid-in capital
Retained earnings (Accumulated deficit)
Accumulated other comprehensive income
Total Shareholders’ Equity (Deficit)
Total Liabilities, Commitments and Contingencies and Shareholders’ Equity (Deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support